"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.